Like pls_老虎社区_美港股上老虎

2021-11-26

Like pls

Europe's CHMP Backs Pfizer/BioNTech's COVID-19 Shot For Kids Aged 5-11 Years

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":877656874,"tweetId":"877656874","gmtCreate":1637928879231,"gmtModify":1637928879352,"author":{"id":3560481430779928,"idStr":"3560481430779928","authorId":3560481430779928,"authorIdStr":"3560481430779928","name":"Raymond杨","avatar":"https://static.tigerbbs.com/a0e904d9a1021ec74841e99e765cf608","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like pls</p></body></html>","htmlText":"<html><head></head><body><p>Like pls</p></body></html>","text":"Like pls","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/877656874","repostId":1100120493,"repostType":4,"repost":{"id":"1100120493","pubTimestamp":1637928580,"share":"https://www.laohu8.com/m/news/1100120493?lang=&edition=full","pubTime":"2021-11-26 20:09","market":"us","language":"en","title":"Europe's CHMP Backs Pfizer/BioNTech's COVID-19 Shot For Kids Aged 5-11 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1100120493","media":"Benzinga","summary":"The European Medicines Agency's (EMA) human medicines committee (CHMP) recommended using Pfizer Inc-","content":"<p>The European Medicines Agency's (EMA) human medicines committee (CHMP)&nbsp;recommended using&nbsp;<b>Pfizer Inc</b>-&nbsp;<b>BioNTech SE's</b>'s COVID-19 vaccine, Comirnaty, for children between 5 to 11.</p>\n<ul>\n <li>Pfizer-BioNTech's vaccine will be given in two 10-microgram doses three weeks apart as an injection in the upper arm, per the EMA recommendation.</li>\n <li>Adult doses of the vaccine contain 30 micrograms.</li>\n <li>Pfizer / BioNTech's vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children aged 5 to 11.</li>\n <li>\"The benefits of Comirnaty in children aged 5 to 11 outweigh the risks, particularly in those with conditions that increase the risk of severe COVID-19,\" the EMA said.</li>\n <li>While final approval is up to the European Commission, an&nbsp;EU source told Reuters&nbsp;that a decision would likely come on Friday.</li>\n <li>\"Today's recommendation (...) is clear the BioNTech-Pfizer vaccine is safe and effective for young children and can offer them additional protection,\" EU health commissioner Stella Kyriakides said on Twitter.</li>\n <li>The companies&nbsp;expect initial data from an ongoing trial&nbsp;in younger children aged 2-5 years in Q4 and kids aged six months to 2 years in Q1 of 2022, with full data readouts to follow.</li>\n <li><b>Price Action:</b>&nbsp;PFE shares are up 5.52% at $53.7, BNTX shares are up 7.30% at $327 during the premarket session on the last check Friday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe's CHMP Backs Pfizer/BioNTech's COVID-19 Shot For Kids Aged 5-11 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope's CHMP Backs Pfizer/BioNTech's COVID-19 Shot For Kids Aged 5-11 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/24301642/europes-chmp-backs-pfizerbiontechs-covid-19-shot-for-kids-aged-5-11-years><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Medicines Agency's (EMA) human medicines committee (CHMP) recommended using Pfizer Inc- BioNTech SE's's COVID-19 vaccine, Comirnaty, for children between 5 to 11.\n\nPfizer-BioNTech's ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/24301642/europes-chmp-backs-pfizerbiontechs-covid-19-shot-for-kids-aged-5-11-years\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.benzinga.com/general/biotech/21/11/24301642/europes-chmp-backs-pfizerbiontechs-covid-19-shot-for-kids-aged-5-11-years","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100120493","content_text":"The European Medicines Agency's (EMA) human medicines committee (CHMP) recommended using Pfizer Inc- BioNTech SE's's COVID-19 vaccine, Comirnaty, for children between 5 to 11.\n\nPfizer-BioNTech's vaccine will be given in two 10-microgram doses three weeks apart as an injection in the upper arm, per the EMA recommendation.\nAdult doses of the vaccine contain 30 micrograms.\nPfizer / BioNTech's vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children aged 5 to 11.\n\"The benefits of Comirnaty in children aged 5 to 11 outweigh the risks, particularly in those with conditions that increase the risk of severe COVID-19,\" the EMA said.\nWhile final approval is up to the European Commission, an EU source told Reuters that a decision would likely come on Friday.\n\"Today's recommendation (...) is clear the BioNTech-Pfizer vaccine is safe and effective for young children and can offer them additional protection,\" EU health commissioner Stella Kyriakides said on Twitter.\nThe companies expect initial data from an ongoing trial in younger children aged 2-5 years in Q4 and kids aged six months to 2 years in Q1 of 2022, with full data readouts to follow.\nPrice Action: PFE shares are up 5.52% at $53.7, BNTX shares are up 7.30% at $327 during the premarket session on the last check Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":827,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/877656874"}